Scientists from the German Cancer Research Center (DKFZ) and ShanghaiTech University have developed an innovative method for ...

A study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence ...

Scientists have developed an innovative method for growing brain tumors of individual patients in the laboratory that mimic the original structure and the molecular property of the parental tumor as ...

A follow-up of the ShortHER trial suggests tumor-infiltrating lymphocytes (TILs) can help identify patients who may benefit ...

There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for patients with stage 3 or 4 kidney cancer, who face high recurrence risk.

Companion Diagnostics Market Companion Diagnostics Market Dublin, Feb. 13, 2025 (GLOBE NEWSWIRE) -- The "Companion ...

SAN FRANCISCO -- Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when ...

A neoantigen-targeting personalized cancer vaccine may be effective as adjuvant therapy in patients with high-risk clear cell renal cell carcinoma, phase 1 data suggest.

Sidra Medicine, a member of Qatar Foundation, was recently honored with the BRIO 8 Award1 from Qatar Research, Development ...

Baylor College of Medicine in Houston is at the forefront of advancements in breast cancer treatment by pioneering a "right-sizing surgery", potentially eliminating the need for surgery, chemotherapy, ...

Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...